Sermorelin
Also known as: Geref, GRF 1-29
Clinical Status
Previously FDA Approved (discontinued) — off-label use continues.
Mechanism of Action
Bioidentical to the active portion of endogenous GHRH. Stimulates the pituitary's natural production and release of growth hormone, maintaining normal feedback mechanisms.
Dosing Defaults
Dose
200-500 mcg
Frequency
1x daily
Administration
Subcutaneous injection at bedtime
Timing
Before bed (fasted)
Food
fasted
Duration
3-6 months
Dose range: 100-500 mcg daily
Mimics natural GHRH and works best before sleep to enhance natural nighttime GH release.
Side Effects
- •Facial flushing
- •Injection site reactions
- •Headache
- •Nausea
- •Dizziness
- •Joint pain
- •Water retention
Contraindications & Warnings
- ⚠Active malignancy
- •Not medical advice
Compare
Compare Sermorelin with another peptide side-by-side.
Ad
Related Growth Hormone Peptides
This information is for educational purposes only and is not medical advice. Dosing data is based on research literature and community reports. Always consult a qualified healthcare provider before using any peptide.